Alpha-aminoadipic and alpha-ketoadipic aciduria

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Alpha-aminoadipic and alpha-ketoadipic aciduria
Synonyms	Alpha-aminoadipic aciduria, Alpha-ketoadipic aciduria
Pronounce
Specialty	Medical genetics
Symptoms	Developmental delay, seizures, hypotonia
Complications	N/A
Onset	Infancy or early childhood
Duration	Lifelong
Types	N/A
Causes	Mutations in the DHTKD1 gene
Risks	Family history of the condition
Diagnosis	Urine organic acid test, genetic testing
Differential diagnosis	Other organic acidurias
Prevention	N/A
Treatment	Dietary management, vitamin B6 supplementation
Medication
Prognosis	Variable, depending on severity
Frequency	Rare
Deaths	N/A

A rare metabolic disorder

Template:Medical condition (new) Alpha-aminoadipic and alpha-ketoadipic aciduria is a rare metabolic disorder characterized by the accumulation of specific organic acids in the body. This condition is part of a group of disorders known as amino acid metabolism disorders, which affect the body's ability to break down certain amino acids.

Pathophysiology

Alpha-aminoadipic and alpha-ketoadipic aciduria is caused by a deficiency in the enzymes involved in the lysine degradation pathway. Specifically, the disorder is linked to defects in the enzymes that convert alpha-aminoadipic acid and alpha-ketoadipic acid into their subsequent metabolites. This leads to the accumulation of these acids in the body, which can be detected in the urine.

Genetics

Autosomal recessive inheritance pattern

The disorder is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the defective gene, one from each parent, to be affected. The specific genes involved in this condition are not well characterized, but they are believed to be involved in the enzymatic steps of lysine degradation.

Clinical Presentation

Individuals with alpha-aminoadipic and alpha-ketoadipic aciduria may present with a variety of symptoms, which can range from mild to severe. Common symptoms include developmental delay, hypotonia, and seizures. In some cases, affected individuals may also experience intellectual disability and other neurological issues.

Diagnosis

The diagnosis of alpha-aminoadipic and alpha-ketoadipic aciduria is typically made through urine organic acid analysis, which reveals elevated levels of alpha-aminoadipic acid and alpha-ketoadipic acid. Additional tests, such as genetic testing, may be used to confirm the diagnosis and identify the specific genetic mutations involved.

Management

There is currently no cure for alpha-aminoadipic and alpha-ketoadipic aciduria, and treatment is primarily supportive. Management strategies may include dietary modifications to reduce the intake of lysine and other amino acids that contribute to the accumulation of toxic metabolites. In some cases, anticonvulsant medications may be prescribed to manage seizures.

Prognosis

The prognosis for individuals with alpha-aminoadipic and alpha-ketoadipic aciduria varies depending on the severity of the condition and the effectiveness of management strategies. Early diagnosis and intervention can improve outcomes and quality of life for affected individuals.

See also

• Metabolic disorder
• Amino acid metabolism disorder
• Lysine degradation pathway